Clifford Chance advises Emirates Growth Fund on landmark first investment in Tarmeem Healthcare Holding Ltd

Clifford Chance has advised Emirates Growth Fund Limited (EGF), the UAE’s flagship growth capital platform backed by Emirates Development Bank (EDB), on its inaugural investment: a strategic minority stake in Tarmeem Healthcare Holding Ltd, a rapidly growing healthcare provider in the UAE. The transaction marks a significant milestone for EGF as it launches its investment portfolio aimed at scaling founder-led SMEs in sectors critical to the UAE’s economic future, including healthcare, manufacturing, food security, and advanced technology.

Founded in 2019 by Dr. Ali Al Suwaidi, Tarmeem Healthcare Holding operates the Tarmeem Orthopedic and Spine Specialty Hospital in Abu Dhabi, along with medical centres in Khalifa City A and Al Ain. EGF’s investment will support Tarmeem’s expansion and further its mission to deliver premium, patient-centric care using cutting-edge technologies and clinical excellence.

Clifford Chance provided end-to-end legal support to EGF, advising on all aspects of the investment, including corporate M&A, healthcare, real estate and structuring matters. The Clifford Chance team was led by corporate partner Daud Khan and senior associate Jordan Knowles, supported by a core team including senior associate Sima Al Baterni, and associate Mehran Azzam.

Daud Khan, lead Partner, commented: “We are proud to have supported Emirates Growth Fund on this strategic and pioneering transaction. Tarmeem Healthcare Holding is a true success story. EGF’s investment underscores the exceptional value and growth potential of healthcare assets in the UAE. This deal is a testament to the strength and resilience of the UAE’s healthcare sector.”

This transaction builds on Clifford Chance’s strong track record advising on high-profile transactions in the Healthcare sector in the Middle East and globally, including the recent take-private of Hong Kong-listed Kangji Medical by a consortium led by TPG.